Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERIPTO Protocol for Post-Traumatic Knee Osteoarthritis
NCT04222140Unknown
- Sponsor
- Affinity Health Research Institute
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Polymer-based Nanoparticles, Adipose-derived MSCs, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma and hyaluronic acid in Post-traumatic osteoarthritis of the knee (PTOA) (2 arms), sponsored by Affinity Health Research Institute. Primary endpoints: Kellgren-Lawrence Grade at 1 year and MRI Evaluation of Cartilage and Meniscal Growth at 1 year. Status: unknown.
02
Drugs
platelet-rich plasmahyaluronic acid
03
Conditions
Post-traumatic osteoarthritis of the knee (PTOA)
Beyond the preview
Go deeper on NCT04222140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222140.